BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 12633696)

  • 1. Cytomegalovirus antibody status of donor/recipient does not influence the incidence of bronchiolitis obliterans syndrome in lung transplantation.
    Luckraz H; Sharples L; McNeil K; Wreghitt T; Wallwork J
    J Heart Lung Transplant; 2003 Mar; 22(3):287-91. PubMed ID: 12633696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are heart-lung transplant recipients protected from developing bronchiolitis obliterans syndrome?
    Moffatt-Bruce SD; Karamichalis J; Robbins RC; Whyte RI; Theodore J; Reitz BA
    Ann Thorac Surg; 2006 Jan; 81(1):286-91; discussion 291. PubMed ID: 16368382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treated cytomegalovirus pneumonia is not associated with bronchiolitis obliterans syndrome.
    Tamm M; Aboyoun CL; Chhajed PN; Rainer S; Malouf MA; Glanville AR
    Am J Respir Crit Care Med; 2004 Nov; 170(10):1120-3. PubMed ID: 15297275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipients.
    Johansson I; Mårtensson G; Nyström U; Nasic S; Andersson R
    BMC Infect Dis; 2013 Dec; 13():582. PubMed ID: 24325216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Impact of Cytomegalovirus Serologic Status on Lung Transplantation in the United States.
    Kurihara C; Fernandez R; Safaeinili N; Akbarpour M; Wu Q; Budinger GRS; Bharat A
    Ann Thorac Surg; 2019 Apr; 107(4):1046-1052. PubMed ID: 30476471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome.
    Valentine VG; Gupta MR; Walker JE; Seoane L; Bonvillain RW; Lombard GA; Weill D; Dhillon GS
    J Heart Lung Transplant; 2009 Feb; 28(2):163-9. PubMed ID: 19201342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of association between beta-herpesvirus infection and bronchiolitis obliterans syndrome in lung transplant recipients in the era of antiviral prophylaxis.
    Manuel O; Kumar D; Moussa G; Chen MH; Pilewski J; McCurry KR; Studer SM; Crespo M; Husain S; Humar A
    Transplantation; 2009 Mar; 87(5):719-25. PubMed ID: 19295317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.
    Heng D; Sharples LD; McNeil K; Stewart S; Wreghitt T; Wallwork J
    J Heart Lung Transplant; 1998 Dec; 17(12):1255-63. PubMed ID: 9883768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended ganciclovir prophylaxis in lung transplantation.
    Perreas KG; McNeil K; Charman S; Sharples LD; Wreghitt T; Wallwork J
    J Heart Lung Transplant; 2005 May; 24(5):583-7. PubMed ID: 15896756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined CMV prophylaxis improves outcome and reduces the risk for bronchiolitis obliterans syndrome (BOS) after lung transplantation.
    Ruttmann E; Geltner C; Bucher B; Ulmer H; Höfer D; Hangler HB; Semsroth S; Margreiter R; Laufer G; Müller LC
    Transplantation; 2006 May; 81(10):1415-20. PubMed ID: 16732179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1.
    Burton CM; Iversen M; Carlsen J; Mortensen J; Andersen CB; Steinbrüchel D; Scheike T
    J Heart Lung Transplant; 2009 Sep; 28(9):888-93. PubMed ID: 19716040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchiolitis obliterans syndrome and early human cytomegalovirus DNAaemia dynamics after lung transplantation.
    Westall GP; Michaelides A; Williams TJ; Snell GI; Kotsimbos TC
    Transplantation; 2003 Jun; 75(12):2064-8. PubMed ID: 12829913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chlamydia pneumoniae serology in donors and recipients and the risk of bronchiolitis obliterans syndrome after lung transplantation.
    Kotsimbos TC; Snell GI; Levvey B; Spelman DW; Fuller AJ; Wesselingh SL; Williams TJ; Ostergaard L
    Transplantation; 2005 Feb; 79(3):269-75. PubMed ID: 15699755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is transplant operation important in determining posttransplant risk of bronchiolitis obliterans syndrome in lung transplant recipients?
    Hadjiliadis D; Davis RD; Palmer SM
    Chest; 2002 Oct; 122(4):1168-75. PubMed ID: 12377838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-organ transplantation: is there a protective effect against acute and chronic rejection?
    Pinderski LJ; Kirklin JK; McGiffin D; Brown R; Naftel DC; Young KR; Smith K; Bourge RC; Tallaj JA; Rayburn BK; Benza R; Zorn G; Leon K; Wille K; Deierhoi M; George JF
    J Heart Lung Transplant; 2005 Nov; 24(11):1828-33. PubMed ID: 16297789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human leukocyte antigen mismatches predispose to the severity of bronchiolitis obliterans syndrome after lung transplantation.
    Chalermskulrat W; Neuringer IP; Schmitz JL; Catellier DJ; Gurka MJ; Randell SH; Aris RM
    Chest; 2003 Jun; 123(6):1825-31. PubMed ID: 12796156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome.
    Smith MA; Sundaresan S; Mohanakumar T; Trulock EP; Lynch JP; Phelan DL; Cooper JD; Patterson GA
    J Thorac Cardiovasc Surg; 1998 Nov; 116(5):812-20. PubMed ID: 9806388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor factors are associated with bronchiolitis obliterans syndrome after lung transplantation.
    Hennessy SA; Hranjec T; Swenson BR; Kozower BD; Jones DR; Ailawadi G; Kron IL; Lau CL
    Ann Thorac Surg; 2010 May; 89(5):1555-62. PubMed ID: 20417777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bronchiolitis obliterans syndrome development in lung transplantation patients.
    Parada MT; Alba A; Sepúlveda C
    Transplant Proc; 2010; 42(1):331-2. PubMed ID: 20172344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk, prevention, and outcome of cytomegalovirus after pediatric lung transplantation.
    Danziger-Isakov LA; Worley S; Michaels MG; Arrigain S; Aurora P; Ballmann M; Boyer D; Conrad C; Eichler I; Elidemir O; Goldfarb S; Mallory GB; Mogayzel PJ; Parakininkas D; Solomon M; Visner G; Sweet S; Faro A
    Transplantation; 2009 May; 87(10):1541-8. PubMed ID: 19461492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.